AMIR (Artificial Medical Intelligence Researcher) transforms weeks of pharmaceutical research into hours — generating comprehensive development dossiers from a single condition input.
Corbus Medical is focused exclusively on developing intelligent tools for pharmaceutical research and clinical development.
We believe the biggest breakthroughs in medicine are limited not by scientific knowledge, but by the time and resources required to synthesize it. Our AI platform eliminates bottlenecks in early-stage pharmaceutical research — enabling researchers, biotech firms, and academic institutions to move from hypothesis to action in hours instead of weeks.
Pharmaceutical R&D teams, biotech startups, academic researchers, clinical research organizations, and regulatory consultants worldwide.
From a single condition input, AMIR orchestrates an 80+ stage AI pipeline to produce a comprehensive pharmaceutical development dossier — covering literature synthesis, therapeutic hypotheses, regulatory strategy, clinical trial designs, IP analysis, and investor materials.
Deep analysis across 8 research domains including epidemiology, pathophysiology, and current therapeutics
10 ranked therapeutic hypotheses with mechanism of action, novelty scoring, and detailed deep-dives
Global regulatory strategy for FDA, EMA, PMDA, and NMPA with clinical trial concepts and protocol synopses
200+ page PDF with clickable table of contents, budget projections, IP strategy, and investor materials
Every dossier is a comprehensive research artifact designed for real-world decision-making.
Comprehensive analysis across 8 research domains — epidemiology, pathophysiology, genomics, current therapeutics, unmet needs, emerging research, biomarkers, and competitive landscape.
10 ranked therapeutic hypotheses with detailed mechanism of action analysis, novelty scoring, and feasibility assessments for each candidate approach.
Global regulatory analysis spanning FDA, EMA, PMDA, and NMPA — with pathway recommendations, precedent analysis, and designation strategies.
Complete clinical trial concepts with protocol synopses, endpoint selection, patient population criteria, and statistical design frameworks.
Patent landscape analysis, freedom-to-operate assessment, and intellectual property strategy recommendations for each therapeutic hypothesis.
Development cost projections, timeline estimates, market sizing, and investor-ready summaries for each recommended therapeutic pathway.
Choose the report tier that matches your research depth requirements. All tiers generate a complete development dossier with clickable table of contents.
| Report Tier | Research Domains | Hypotheses | Detailed Deep-Dives | Regulatory Regions | Delivery |
|---|---|---|---|---|---|
| Quick | 4 | 5 | 3 | 2 | ~2 hours |
| Detailed | 6 | 8 | 5 | 3 | ~3 hours |
| Comprehensive | 8 | 10 | All 10 | 4 (FDA, EMA, PMDA, NMPA) | ~4 hours |
Contact us for pricing. Special pricing available for academic researchers and institutions.
Research data demands the highest standards of security and privacy. We take that responsibility seriously.
Tell us about your research needs, and we'll schedule a personalized demonstration of AMIR's capabilities. We typically respond within one business day.